Skip to main content
. 2018 Feb 1;2018(2):CD001269. doi: 10.1002/14651858.CD001269.pub6

pcb Lin 2012.

Methods Retrospective cohort study
Participants A total of 396 pregnant Taiwanese women were included in the study, of which 198 received influenza vaccine during pregnancy
Interventions Monovalent H1N1 unadjuvanted, inactivated, split‐virus vaccine AdimFlu‐S (Adimmune Corporation; Taichung, Taiwan) containing 15 g of New York Medical College X‐179A reassortant of the A/California/7/2009 (H1N1)‐like strain in 0.5 mL dose
Outcomes Systemic and local adverse events in vaccinated mothers
In newborns:

  • Hyperbilirubinaemia

  • Contact dermatitis

  • Upper respiratory tract infection

  • Seborrhoeic dermatitis

  • Respiratory distress
Notes Government funded
Risk of bias
Bias Authors' judgement Support for judgement
PCS/RCS ‐ selection exposed cohort 
 All outcomes Unclear risk Unclear
PCS/RCS ‐ selection non‐exposed cohort 
 All outcomes Unclear risk Unclear
PCS/RCS ‐ comparability 
 All outcomes High risk  
PCS/RCS ‐ assessment of outcome 
 All outcomes Low risk Medical records
Summary assessment High risk